STORY:
A 67-year-old woman from Maryland was diagnosed with pancreatic adenocarcinoma, presenting as a 2.3 × 2.2 cm mass in the pancreatic head. She began neoadjuvant FOLFIRINOX chemotherapy in late September 2024, completing 6 aggressive cycles by January 2025.
Unfortunately, a follow-up MRI on January 7, 2025, showed no improvement and possible progression to Stage 4 with suspected liver metastases. At this point, her CA19-9 tumor marker was 942.
TREATMENT PLAN (AFTER FAILURE OF CHEMO):
In early March 2025, she contacted Dr. William Makis and started the following integrative protocol:
- Ivermectin: 1.5 mg/kg/day
- Fenbendazole: 1000 mg/day
- CBD Oil: 100 mg/day
This was continued without further chemotherapy.
RESULTS:
✅ CT Scan (May 2025):
- “Previous mass pancreatic head is no longer visualized”
- “Liver enhancing nodules are not seen”
- No signs of infiltrates or lung disease
✅ Tumor marker CA19-9 dropped from 942 to 9
✅ Patient is now CANCER FREE according to imaging and tumor marker tests.
This is a perfect example of what can happen when the right tools are applied after conventional treatments fail. The tumor showed no response to FOLFIRINOX, but after just 2.5 months of Ivermectin + Fenbendazole, the pancreatic mass and liver lesions completely disappeared.
This case reminds us that even aggressive, late-stage cancers like pancreatic adenocarcinoma can respond dramatically when metabolism and immune signaling are corrected.
More proof that the metabolic repurposed-drug approach is changing outcomes for the so-called “incurable.”
Source: Dr. William Makis
For more case reports like this one, consider joining my exclusive platform here
